Shenol A, Tenente R, Luckmann M, Frimurer T, Schwartz T
Nat Commun. 2024; 15(1):5364.
PMID: 38918366
PMC: 11199501.
DOI: 10.1038/s41467-024-49536-y.
Li N, Niu L, Liu Y, Wang Y, Su X, Xu C
J Nanobiotechnology. 2024; 22(1):241.
PMID: 38735933
PMC: 11089779.
DOI: 10.1186/s12951-024-02506-4.
Yadav M, Sarma P, Maharana J, Ganguly M, Mishra S, Zaidi N
Nat Commun. 2024; 15(1):1939.
PMID: 38431681
PMC: 10908815.
DOI: 10.1038/s41467-024-46239-2.
Pan X, Ye F, Ning P, Zhang Z, Li X, Zhang B
Cell Discov. 2023; 9(1):118.
PMID: 38012147
PMC: 10682194.
DOI: 10.1038/s41421-023-00610-7.
Mao C, Gao M, Zang S, Zhu Y, Shen D, Chen L
Nat Commun. 2023; 14(1):7620.
PMID: 37993467
PMC: 10665550.
DOI: 10.1038/s41467-023-43537-z.
Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2.
Cheng L, Sun S, Wang H, Zhao C, Tian X, Liu Y
Signal Transduct Target Ther. 2023; 8(1):364.
PMID: 37743365
PMC: 10518311.
DOI: 10.1038/s41392-023-01625-y.
Structural basis of hydroxycarboxylic acid receptor signaling mechanisms through ligand binding.
Suzuki S, Tanaka K, Nishikawa K, Suzuki H, Oshima A, Fujiyoshi Y
Nat Commun. 2023; 14(1):5899.
PMID: 37736747
PMC: 10516952.
DOI: 10.1038/s41467-023-41650-7.
Structural insights into the human niacin receptor HCA2-G signalling complex.
Yang Y, Kang H, Gao R, Wang J, Han G, DiBerto J
Nat Commun. 2023; 14(1):1692.
PMID: 36973264
PMC: 10043007.
DOI: 10.1038/s41467-023-37177-6.
Synthesis, X-ray diffraction analysis, quantum chemical studies and -amylase inhibition of probenecid derived -alkylphthalimide-oxadiazole-benzenesulfonamide hybrids.
Khan B, Hamdani S, Ahmed M, Hameed S, Ashfaq M, Shawky A
J Enzyme Inhib Med Chem. 2022; 37(1):1464-1478.
PMID: 35616297
PMC: 9154803.
DOI: 10.1080/14756366.2022.2078969.
Selected β-, β- and β-Amino Acid Heterocyclic Derivatives and Their Biological Perspective.
Bachor U, Maczynski M
Molecules. 2021; 26(2).
PMID: 33467741
PMC: 7829935.
DOI: 10.3390/molecules26020438.
G protein-coupled receptors not currently in the spotlight: free fatty acid receptor 2 and GPR35.
Milligan G
Br J Pharmacol. 2017; 175(13):2543-2553.
PMID: 28940377
PMC: 6003633.
DOI: 10.1111/bph.14042.
Antiatherosclerotic Effects of 1-Methylnicotinamide in Apolipoprotein E/Low-Density Lipoprotein Receptor-Deficient Mice: A Comparison with Nicotinic Acid.
Mateuszuk L, Jasztal A, Maslak E, Gasior-Glogowska M, Baranska M, Sitek B
J Pharmacol Exp Ther. 2015; 356(2):514-24.
PMID: 26631491
PMC: 6047228.
DOI: 10.1124/jpet.115.228643.
One-pot synthesis of densely functionalized cyclic β-aminoesters containing four stereocenters, based on a Et3N-promoted pseudo five-component reaction.
Yao J, Zhou L, Tan C, Wang C
Mol Divers. 2014; 19(1):43-53.
PMID: 25252998
DOI: 10.1007/s11030-014-9554-2.
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.
Alexander S, Benson H, Faccenda E, Pawson A, Sharman J, Spedding M
Br J Pharmacol. 2014; 170(8):1459-581.
PMID: 24517644
PMC: 3892287.
DOI: 10.1111/bph.12445.
G protein-coupled receptors for energy metabolites as new therapeutic targets.
Blad C, Tang C, Offermanns S
Nat Rev Drug Discov. 2012; 11(8):603-19.
PMID: 22790105
DOI: 10.1038/nrd3777.
High dietary niacin may increase prostaglandin formation but does not increase tumor formation in ApcMin/+ mice.
Kwong A, Tippin B, Materi A, Buslon V, French S, Lin H
Nutr Cancer. 2011; 63(6):950-9.
PMID: 21774590
PMC: 3224853.
DOI: 10.1080/01635581.2011.590266.
Therapeutic potential of β-arrestin- and G protein-biased agonists.
Whalen E, Rajagopal S, Lefkowitz R
Trends Mol Med. 2010; 17(3):126-39.
PMID: 21183406
PMC: 3628754.
DOI: 10.1016/j.molmed.2010.11.004.
